https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47181 1 As of 26 April 2020, it has infected over three million people worldwide and caused more than 200 000 deaths.² Chronic liver diseases from HCV, HBV, alcoholism or non-alcoholic fatty liver disease (NAFLD) represent a major disease burden in the world. Around 1.5 billion people have chronic liver diseases worldwide, and it causes around two million deaths per year. While self-resolving elevations of transaminases are reported in 15%–54% of patients with COVID-19, those with more severe disease experience worse liver injury.^3–5 An open international registry, SECURE-Cirrhosis, is reporting a mortality rate of 40% among the 118 patients with cirrhosis.⁶ Thus, patients with chronic liver disease represent a vulnerable population who are at higher risk of acquiring COVID-19 and suffering from its complications.^{7 8}]]> Wed 14 Dec 2022 15:56:14 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48183 Sat 11 Mar 2023 12:23:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49866 Fri 15 Sep 2023 15:25:57 AEST ]]>